Zobrazeno 1 - 10
of 280
pro vyhledávání: '"Robert A. Hutchins"'
Autor:
Nicholas E, Dudenhoefer, Carl W, Noble, Michael R, Petersen, Robert E, Foster, Christopher D, Riemann, Robert A, Sisk, Robert K, Hutchins, Daniel M, Miller
Publikováno v:
Retina. 42:1568-1573
To assess the long-term efficacy of intravitreal antivascular endothelial growth factor injections (IVI), alone or in combination with verteporfin photodynamic therapy (IVI/PDT), for management of choroidal neovascularization secondary to presumed oc
Publikováno v:
Urology Journal, Vol 7, Iss 1, Pp 66-68 (2010)
Externí odkaz:
https://doaj.org/article/5e3bf3d6e72a42559b203717c8ba5a3d
Autor:
Robert A. Sisk, Robert K. Hutchins, Christopher D. Riemann, Luke B Lindsell, Robert E. Foster, Michael R. Petersen, Daniel M. Miller
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Luke B Lindsell, Robert A Sisk, Daniel M Miller, Robert E Foster, Michael R Petersen, Christopher D Riemann, Robert K Hutchins Cincinnati Eye Institute, Department of Ophthalmology, University of Cincinnati, Cincinnati, OH, USA Objective: To assess t
Autor:
Simon J, McCluney, Alexandros A, Giakoustidis, Angela, Segler, Juliane, Bissel, Robert L, Miller, Roberto, Valente, Robert R, Hutchins, Ajit, Abraham, Satyajit, Bhattacharya, Hemant M, Kocher
Publikováno v:
ANZ journal of surgery. 88(11)
Colorectal cancer is one of the most common malignancies worldwide; whilst approximately 20% of patients have hepatic disease at presentation. Hepatic resection remains the gold standard of care; however, it is associated with significant morbidity.
Autor:
Daniel M. Miller, Christopher D. Riemann, Adeel H. Shaikh, Robert E. Foster, Michael R. Petersen, Brian W. Toussaint, Robert K. Hutchins, Robert A. Sisk
Publikováno v:
Ophthalmic Surgery, Lasers and Imaging Retina. 46:62-66
BACKGROUND AND OBJECTIVE: To test the hypothesis that although intravitreal aflibercept (IVA) is expected to be more expensive, the extra cost of treatment would not result in additional vision gain compared with intravitreal bevacizumab (IVB) for th
Autor:
Robert Maynard Hutchins
Publikováno v:
Echoes of Insight ISBN: 9780891126171
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3464c6ceb56540fc6e74afc48062dc97
https://doi.org/10.2307/j.ctv310vnb6.14
https://doi.org/10.2307/j.ctv310vnb6.14
Autor:
Stephan G Dixon, Ping Wang, Robert K. Hutchins, Charles J. Glueck, Robert A. Sisk, Vybhav Jetty, Carl T Bruce
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Stephan G Dixon,1 Carl T Bruce,1 Charles J Glueck,1 Robert A Sisk,2,3 Robert K Hutchins,2,3 Vybhav Jetty,1 Ping Wang1 1Cholesterol, Metabolism, and Thrombosis Center, Jewish Hospital of Cincinnati, 2Cincinnati Eye Institute, 3Department of Ophthalmol
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Will S Kurtz,1 Charles J Glueck,1 Robert K Hutchins,2,3 Robert A Sisk,2,3 Ping Wang1 1Cholesterol, Metabolism, and Thrombosis Center, Jewish Hospital of Cincinnati, 2Cincinnati Eye Institute, 3Department of Ophthalmology, University of Cincinnati Col
Autor:
Christopher D. Riemann, Daniel M. Miller, Shawn A. Lewis, Robert K. Hutchins, Robert E. Foster, Robert A. Sisk, Douglas A. Cionni, Michael R. Petersen
Publikováno v:
Ophthalmology. 119:327-332
Purpose To assess the long-term outcomes of intravitreal bevacizumab (IVB) in the treatment of choroidal neovascularization (CNV) secondary to presumed ocular histoplasmosis syndrome (POHS). Design Retrospective, comparative case series. Participants